Clinical Characteristics of Heart Failure With Preserved Ejection Fraction in Children
-
- Masutani Satoshi
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
-
- Saiki Hirofumi
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
-
- Kurishima Clara
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
-
- Ishido Hirotaka
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
-
- Tamura Masanori
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
-
- Senzaki Hideaki
- Department of Pediatric Cardiology, Saitama Medical Center, Saitama Medical University
書誌事項
- タイトル別名
-
- Heart Failure With Preserved Ejection Fraction in Children
- – Hormonal Imbalance Between Aldosterone and Brain Natriuretic Peptide –
この論文をさがす
説明
Background: There is no information on heart failure (HF) with preserved ejection fraction (HFpEF, EF >50%) in children. Methods and Results: Through a retrospective review of 3,907 pediatric patients with cardiovascular disease, we examined the characteristics of pediatric HFpEF over a 10-year period. We identified 18 patients with HFpEF (0.5%). They were predominantly young children (1.1±0.9 years, no sex preponderance), who had undergone surgery for congenital heart disease. They also had concentric hypertrophy and diastolic dysfunction with elevated blood pressure. Notably, HFpEF patients had more pronounced elevation of serum aldosterone but less pronounced elevation of plasma brain natriuretic peptide (BNP) than 22 systolic HF patients (SHF, EF ≤50%) (aldosterone: 1,375±1,200 vs. 511±563pg/ml, P<0.05, and BNP: 101±141 vs. 749±818pg/ml, P<0.005). Consequently, the aldosterone/BNP ratio was significantly higher in HFpEF (38±63) than in SHF (1.7±1.9, P<0.05), and an aldosterone/BNP ratio of 10.3 or higher best predicted HFpEF (area under the curve=0.89). The HF mortality rate was significantly lower in the HFpEF than in the SHF cases, and HF symptoms showed amelioration in 61% of patients during the follow-up period of 4.2±2.6 years. Conclusions: HFpEF does exist in children. A common pathophysiology underlies childhood and adult HFpEF despite considerable epidemiological and etiological differences. Future controlled studies are warranted to assess the cause-effect relationship between unique hormonal profiles and HFpEF. (Circ J 2013; 77: 2375–2382)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 77 (9), 2375-2382, 2013
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205103694208
-
- NII論文ID
- 10031191767
- 10031191749
-
- NII書誌ID
- AA11591968
-
- COI
- 1:STN:280:DC%2BC3snoslSmtQ%3D%3D
-
- ISSN
- 13474820
- 13469843
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可